Market Cap
$29.1K
RE
REVBW
REVELATION BIOSCIENCES, INC.
—
Market cap$29.1K
Biotech & Drug Discovery
Snapshot
The big-picture read on REVBW right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
8 funds
Inst. Value
$6.4K
Inst. Activity
1 buys / 1 sells
SEC Reports
1
Price chart 30d -24.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 14, 2026 short_interest_report
Short Interest: REVBW up 46% to 0.0M shares
Settlement 2026-08-14 | Days to cover: 10.24 | ≈0.14% of shares outstanding (est.)
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — TRIM
18,716 shares ($116.00)
Jun 30, 2026 Inst.
Jun 1, 2026 SEC UBS Group AG — DOUBLED
3,532 shares ($28.00)
Revelation Biosciences, Inc. filed an 8-K on June 1, 2026, announcing the release of an updated corporate presentation m
8-K — Impact 2/10
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
1 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 1 neutral · avg impact 2.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 14, 2026
short_interest_report
Short Interest: REVBW up 46% to 0.0M shares
Settlement 2026-08-14 | Days to cover: 10.24 | ≈0.14% of shares outstanding (est.)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own REVBW (from quarterly 13F filings) and who is adding or trimming.
8 institutional holders with $6.4K total value (853,002 shares) as of 2026-Q2. Top holders: LINDEN, Clear, TORONTO.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| LINDEN ADVISORS LP | 337,752 | $2.4K | 37.6% | — |
| Clear Street Group Inc. | 246,934 | $2.0K | 30.6% | — |
| TORONTO DOMINION BANK | 99,050 | $792.00 | 12.4% | — |
| WOLVERINE ASSET MANAGEMENT LLC | 54,752 | $433.00 | 6.8% | DOUBLED +146.6% |
| JANE STREET GROUP, LLC | 50,000 | $395.00 | 6.2% | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 42,266 | $262.00 | 4.1% | — |
| CITADEL ADVISORS LLC | 18,716 | $116.00 | 1.8% | TRIM -42.2% |
| UBS Group AG | 3,532 | $28.00 | 0.4% | DOUBLED +563.9% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | TRIM | 32,400 | 18,716 | -42.2% | $116.00 |
| UBS Group AG | DOUBLED | 532 | 3,532 | +563.9% | $28.00 |
| UBS Group AG | DOUBLED | 272 | 1,300 | +377.9% | $16.00 |
| UBS Group AG | NEAR_EXIT | 2,512 | 272 | -89.2% | $3.00 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 22,202 | 54,752 | +146.6% | $383.00 |
| Walleye Capital LLC | NEAR_EXIT | 187,001 | 10,074 | -94.6% | $71.00 |
| CITADEL ADVISORS LLC | TRIM | 45,853 | 29,400 | -35.9% | $423.00 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 72,202 | 22,202 | -69.3% | $333.00 |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for REVBW.
Shares short
5,973
Settlement Sep 15, 2026
Change vs prior
0.0%
Semi-monthly cycle
Days to cover
1.9
At avg daily volume
Of shares outstanding
≈0.1%
Estimate — not % of float
All REVBW filing & press-release reports (1)
- 8-K reportJun 1, 2026